Zobair Younossi, Linda Henry – 7 February 2014

Fateh Bazerbachi, Elizabeth Aby, John Lake – 7 February 2014

Souvik Sarkar, Joseph K. Lim – 7 February 2014

Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan‐Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski, Riad Salem – 6 February 2014 – Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular carcinoma (HCC) <3 cm; there is interest in expanding the role of ablation to 3‐5 cm. RFA is considered high‐risk when the lesion is in close proximity to critical structures.

Michael Vouche, Ali Habib, Thomas J. Ward, Edward Kim, Laura Kulik, Daniel Ganger, Mary Mulcahy, Talia Baker, Michael Abecassis, Kent T. Sato, Juan‐Carlos Caicedo, Jonathan Fryer, Ryan Hickey, Elias Hohlastos, Robert J. Lewandowski, Riad Salem – 6 February 2014 – Resection and radiofrequency ablation (RFA) are treatment options for hepatocellular carcinoma (HCC) <3 cm; there is interest in expanding the role of ablation to 3‐5 cm. RFA is considered high‐risk when the lesion is in close proximity to critical structures.

Emmy Ludwig – 6 February 2014

Safi Dokmak, Béatrice Aussilhou, François Durand, Valérie Paradis, Jacques Belghiti – 6 February 2014

Safi Dokmak, Béatrice Aussilhou, François Durand, Valérie Paradis, Jacques Belghiti – 6 February 2014

Maureen M.J. Guichelaar, Michael R. Charlton – 6 February 2014

Maureen M.J. Guichelaar, Michael R. Charlton – 6 February 2014